| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Purvalanol B | 212844-54-7 | sc-361300 sc-361300A | 10 mg 50 mg | $199.00 $846.00 | ||
Purvalanol A competitively inhibits ATP binding to CDK2, halting its kinase activity. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Roscovitine selectively binds to the ATP pocket of CDK2, reducing its phosphorylation capabilities. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $259.00 | 41 | |
Flavopiridol inhibits CDK2 by competitive inhibition of ATP and blocks cell cycle progression. | ||||||
Olomoucine | 101622-51-9 | sc-3509 sc-3509A | 5 mg 25 mg | $72.00 $274.00 | 12 | |
Olomoucine mimics the structure of ATP and competes for its binding site on CDK2. | ||||||
Indirubin | 479-41-4 | sc-201531 sc-201531A | 5 mg 25 mg | $114.00 $525.00 | 4 | |
Indirubin intercalates in the ATP-binding site, preventing CDK2 activity. | ||||||
4′-Methylpropiophenone | 5337-93-9 | sc-252233 | 100 g | $66.00 | ||
Butyrolactone binds to CDK2 and alters its conformation, thus inhibiting its function. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
Palbociclib selectively inhibits CDK2 by blocking ATP-binding, disrupting cell division. | ||||||
Ribociclib | 1211441-98-3 | sc-507367 | 10 mg | $450.00 | ||
Ribociclib binds to and inhibits CDK2, leading to G1 phase arrest in the cell cycle. | ||||||
Abemaciclib | 1231929-97-7 | sc-507342 | 10 mg | $110.00 | ||
Abemaciclib binds to CDK2, preventing ATP binding and phosphorylation of target substrates. | ||||||
Dinaciclib | 779353-01-4 | sc-364483 sc-364483A | 5 mg 25 mg | $247.00 $888.00 | 1 | |
Dinaciclib robustly binds to CDK2 and blocks its enzymatic phosphorylation activity. | ||||||